Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-038099

SVP & Chief Financial Officer sold 25,000 shares at $33.71 ($842,750)

  • SVP & Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-06-17 Option exercise +25,000 $7.21 $180,250 152,935 D: show line 1 in the form
Labrucherie Gil M SVP & Chief Financial Officer 2019-06-17 Sale −25,000 $33.71 $842,750 127,935 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $33.71 · $842,750

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-06-17 Option exercise · Stock Option −25,000 50,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…